Predicting Alzheimer’s with AI

A Breakthrough in Early Diagnosis

Tom Kane
Plainly Put
3 min readJul 20, 2024

--

Artist impression, woman with dementia, splash art
Image by Nightcafe

As a retired biochemist and molecular biologist, I have always been fascinated by the intersection of technology and medicine.

Recently, I came across an exciting development that I believe has the potential to revolutionize the way we diagnose and manage Alzheimer’s disease. Researchers from the University of Cambridge have developed an AI-based tool capable of predicting whether a person with early dementia symptoms will remain stable or progress to Alzheimer’s disease with up to 82% accuracy.

Understanding dementia and Alzheimer’s Disease

First, it’s important to clarify that while the terms dementia and Alzheimer’s disease are often used interchangeably, they are not the same. Dementia is an umbrella term for conditions that negatively affect thinking, memory, and a person’s ability to perform daily tasks.

Alzheimer’s disease, on the other hand, is a specific neurological condition and the most common type of dementia, accounting for 60–80% of all dementia diagnoses.

The importance of early diagnosis

Early diagnosis of both dementia and Alzheimer’s disease is crucial to slowing disease progression. However, previous studies have shown that less than half of people with dementia symptoms are ever diagnosed. This is partly because the symptoms of dementia and Alzheimer’s disease often overlap with those of natural age-related cognitive decline, making early diagnosis challenging.

The AI tool: How it works

To address this issue, researchers from the University of Cambridge have developed an AI tool that uses cognitive tests and MRI scan data to predict the progression of Alzheimer’s disease.

The study, published in *eClinical Medicine*, involved using data from over 400 individuals in a U.S.-based research group. The AI tool was then tested on data from another 600 people in the U.S. and 900 participants from memory clinics in the U.K. and Singapore.

Dr. Zoe Kourtzi, a professor of experimental psychology at the University of Cambridge, explained that the AI models were trained and tested on routinely collected data from actual memory clinics, ensuring that the tool would be generalizable to real-world settings.

Impressive Accuracy and Potential Impact

The AI tool demonstrated remarkable accuracy, correctly identifying 82% of participants who went on to develop Alzheimer’s disease and 81% of participants who did not.

This makes the AI tool almost three times more accurate at predicting the progression from early-stage dementia to Alzheimer’s disease than the current standard of care.

Dr. Kourtzi emphasized that this tool could significantly improve patient well-being by identifying individuals who need close monitoring and reducing unnecessary anxiety for those likely to remain stable. Moreover, it could help alleviate the pressure on healthcare resources by reducing the need for invasive and costly diagnostic tests.

Future Directions

While the results are promising, experts like Dr. Manisha Parulekar from Hackensack University Medical Center have called for validation of the AI tool in larger and more diverse populations. This is essential to ensure the tool’s accuracy and generalizability across different demographic groups.

Dr. David Merrill, a geriatric psychiatrist at the Pacific Brain Health Center, highlighted the potential of AI to create accurate predictive models of dementia from commonly collected patient information. He noted that accurately predicting which patients need rapid intervention could help prevent the progression to full-blown dementia.

As someone who has spent a lifetime in the field of biochemistry and molecular biology, I find this development incredibly exciting. The integration of AI in medical diagnostics represents a significant leap forward in our ability to manage and treat Alzheimer’s disease.

I look forward to seeing how this tool evolves and its eventual impact on patient care.

References:

1. Pelc, C. (2024). Scientists create AI tool that helps predict Alzheimer’s with up to 82% accuracy. Medical News Today.

2. Cohen, F. (2024). AI tool may help predict Alzheimer’s risk with almost 80% accuracy. Medical News Today.

3. University of Cambridge. (2024). Artificial intelligence outperforms clinical tests at predicting progress of Alzheimer’s disease.

If you enjoyed reading this, you may also want to explore and subscribe free to this: Click here to get our free weekly Newsletter, Healthwise

click here to read more on this subject: Here’s our Quora Space — Active Longevity — Seniors

--

--

Tom Kane
Plainly Put

Retired Biochemist, Premium Ghostwriter, Top Medium Writer,Editor of Plainly Put and Poetry Genius publications on Medium